• N/A
    Market Cap
  • -70.07%
    1-Year Change
  • Medical Instruments & Supplies
    Industry
Annual
Quarterly
09/30/2025
09/30/2024
09/30/2023
Income Statement
Total Operating Revenue
20.7M
-11.98%
23.5M
+18.57%
19.8M
N/A
Cost of Revenue
14.6M
+4.60%
14.0M
+7.38%
13.0M
N/A
Gross Profit
6.0M
-36.39%
9.5M
+40.06%
6.8M
N/A
Sales and Marketing Expense
1.3M
+21.74%
1.1M
+143.75%
453,311
N/A
Research and Development Expense
-1.6M
+4.03%
-1.5M
-2.95%
-1.5M
N/A
Depreciation and Amortization Expense
243,403
+2.35%
237,823
+5.28%
225,902
N/A
Total Operating Expenses
5.4M
-7.29%
5.9M
+49.69%
3.9M
N/A
Operating Profit
608,182
-83.29%
3.6M
+26.91%
2.9M
N/A
Interest Income
789,070
+69.14%
466,524
+298.01%
117,213
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
789,070
+69.14%
466,524
+298.01%
117,213
N/A
Total Nonoperating Income and Expense
987,635
+81.23%
544,966
+198.31%
182,682
N/A
Income before Taxes
1.6M
-61.86%
4.2M
+29.85%
3.2M
N/A
Income Taxes
214,572
-71.91%
763,879
+122.25%
343,707
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
1.2M
-67.59%
3.7M
+27.71%
2.9M
N/A
Net Income from Continuing Operations Applicable to Common
1.6M
-61.86%
4.2M
+29.85%
3.2M
N/A
Basic EPS and Net Income
0.01
-50.00%
0.02
0.00%
0.02
N/A
Diluted EPS and Net Income
0.01
-50.00%
0.02
0.00%
0.02
N/A
Basic Weighted Average Shares
156.5M
+0.05%
156.5M
+7.81%
145.1M
N/A
Diluted Weighted Average Shares
156.5M
+0.05%
156.5M
+7.81%
145.1M
N/A
Balance Sheet
Cash and Cash Equivalents
7.5M
-8.29%
8.1M
+17.41%
6.9M
N/A
Short-Term Investments
22.2M
+19.05%
18.6M
+90.62%
9.8M
N/A
Cash and Cash Equivalents and Short-Term Investments
29.6M
+10.74%
26.8M
+60.24%
16.7M
N/A
Total Current Assets
44.1M
+3.10%
42.8M
+37.60%
31.1M
N/A
Accumulated Depreciation
4.2M
+2.19%
4.1M
+9.97%
3.8M
N/A
Property and Plant and Equipment and Net
7.9M
+440.67%
1.5M
-1.39%
1.5M
N/A
Total Long-Term Assets
9.2M
+531.74%
1.5M
-1.39%
1.5M
N/A
Total Assets
53.4M
+16.52%
45.8M
+39.20%
32.9M
N/A
Income Taxes Payable
302,317
-73.09%
1.1M
+313.96%
271,423
N/A
Total Short-Term Debt
1.4M
-87.61%
11.3M
+175.28%
4.1M
N/A
Total Current Liabilities
23.8M
+38.73%
17.2M
+92.19%
8.9M
N/A
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
72,645
-24.47%
96,175
N/A
N/A
N/A
Total Liabilities
23.8M
+37.96%
17.2M
+93.27%
8.9M
N/A
Retained Earnings
20.9M
+4.59%
20.0M
+18.28%
16.9M
N/A
Total Stockholders Equity
29.6M
+2.86%
28.8M
+20.17%
24.0M
N/A
Total Shares Outstanding
156.5M
0.00%
156.5M
+0.38%
155.9M
N/A
Cash Flow
Cash from Operating Activities
2.9M
+340.50%
-1.2M
-138.87%
3.1M
N/A
Capital Expenditures
6.6M
+4,473.88%
144,949
+27.22%
113,937
N/A
Cash from Investing Activities
-10.8M
+13.43%
-9.5M
+23.08%
-7.7M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
7.4M
-36.91%
11.7M
+68.64%
6.9M
N/A
Financials Ratio
Gross Margin
29.22%
-27.74%
40.43%
N/A
N/A
N/A
Operating Margin
2.94%
-81.01%
15.48%
N/A
N/A
N/A
Return on Assets
2.40%
-74.28%
9.34%
N/A
N/A
N/A
Return on Equity
4.08%
-70.73%
13.93%
N/A
N/A
N/A
Revenue Growth
-11.98%
-164.50%
18.57%
N/A
N/A
N/A
Current Ratio
1.86
-25.69%
2.50
N/A
N/A
N/A
Cash Ratio
0.31
-33.90%
0.47
N/A
N/A
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow